Rosana Kapeller-Libermann
Director/Board Member at SCHRÖDINGER, INC.
Net worth: - $ as of 31/03/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ramy Farid | M | 59 | 22 years | |
Kira Nelson | F | 55 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | - |
Michael Lynton | M | 64 | 6 years | |
Yvonne Tran | F | 53 | 14 years | |
Arun Oberoi | M | 70 | 2 years | |
Jaren Madden | F | - | 4 years | |
Jeffrey Chodakewitz | M | 68 | 4 years | |
Jay Parrish | M | 49 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 5 years |
David Annis | M | 51 | 17 years | |
Kyle Kuvalanka | M | 56 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 1 years |
Richard Friesner | M | 71 | 34 years | |
Frank Taffy | M | - | 3 years | |
Shane Brauner | M | 47 | 15 years | |
Gary Sender | M | 62 | 5 years | |
Patrick Lorton | M | 40 | 18 years | |
Jenny Herman | F | - | - | |
Gary Ginsberg | M | 61 | 4 years | |
Nancy Thornberry | F | 67 | 5 years | |
Brian Jones | M | - |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | 6 years |
Scott Biller | M | 68 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 3 years |
Karen Akinsanya | M | 56 | 6 years | |
Jake Simson | M | 38 |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | - |
Dominik Naczynski | M | - |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | - |
Jeb Keiper | M | - |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 5 years |
Margaret Dugan | M | 67 | 1 years | |
Allie Nicodermo | F | - | - | |
Jason Hafler | M | 42 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | - |
Robert Abel | M | 42 | 15 years | |
Neil Exter | M | 65 |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | - |
Michael Sinclair | M | 82 |
Tufts University
| 31 years |
Geoffrey Porges | M | 63 | 2 years | |
Kristina Burow | F | 50 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | - |
Jeffrey Hatfield | M | 66 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 2 years |
Abbie Celniker | M | 65 |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | 6 years |
Rui de Britto Álvares Affonso | M | 67 |
University of Campinas
| 38 years |
Mark Iwicki | M | 57 |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | 9 years |
Mathew Halls | M | - | 12 years | |
Steven Kafka | M | 54 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 3 years |
Paul Davie | M | - | 7 years | |
Eli Casdin | M | 51 |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | - |
Luiz Gonzaga de Mello Belluzzo | M | - |
University of Campinas
| 38 years |
Krishna Yeshwant | M | 46 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | - |
George P. Vlasuk | M | - |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | 9 years |
Christopher Bowden | M | 63 |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | 3 years |
Jean Lachowicz | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Joseph Yanchik | M | 60 | 17 years | |
Mona Vernon | F | - |
Tufts University
| 6 years |
Huw Nash | M | 57 | 12 years | |
Gregory Verdine | M | 65 | - | |
Jamie Ebersole | M | - |
Tufts University
| 5 years |
Loren David Walensky | M | - | - | |
Donald Nicholson | M | 67 |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | 4 years |
Joel Lebowitz | M | 60 | 4 years | |
Timothy M. Wright | M | 69 | 6 years | |
Bradley Tirpak | M | 54 |
Tufts University
| 4 years |
Brian Gallagher | M | 54 |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | 7 years |
Roderick J. Cruz | M | - |
Tufts University
| 4 years |
James Wiandt | M | - |
Tufts University
| 4 years |
Ahmet Fadil Ashaboglu | M | 53 |
Tufts University
| 4 years |
Eric S. Klee | M | 53 |
Tufts University
| 4 years |
Essa Khalid Essa Al-Saleh | - | - |
Tufts University
| 3 years |
Matt Sabel | M | - |
Tufts University
| 4 years |
John Moore | M | - |
Tufts University
| 4 years |
Ted Levinson | M | - |
Tufts University
| 3 years |
Roy S. Eappen | M | - |
Tufts University
| 4 years |
Geoffrey Morris Chalmers | M | - |
Tufts University
| 4 years |
Ari S. Goldstein | M | 53 |
Tufts University
| 3 years |
Chris Cowart | M | - |
Tufts University
| 4 years |
Irusha Peiris | M | - |
Tufts University
| 4 years |
Tamara Doi Beck | F | - |
Tufts University
| 4 years |
Robert Edesses | M | - |
Tufts University
| 4 years |
Essa Al-Saleh | M | 53 |
Tufts University
| 3 years |
Ted Kamionek | M | - |
Tufts University
| 4 years |
Eric Michael Weinstein | M | - |
Tufts University
| 4 years |
Gregg Felton | M | 52 |
Tufts University
| 4 years |
Jack McCarthy | M | - |
Tufts University
| 4 years |
Baris Brett | M | 49 |
Tufts University
| 4 years |
Yang Wang | M | 54 |
Tufts University
| 4 years |
Aram Rubinson | M | - |
Tufts University
| 4 years |
Jonathan Sage | M | - |
Tufts University
| 4 years |
Matt Perry | M | - |
Tufts University
| 4 years |
James Henry Friedland | M | - |
Tufts University
| 4 years |
Diego Rotsztain | M | 53 |
Tufts University
| 4 years |
Joshua R. Cammaker | M | - |
Tufts University
| 4 years |
Jonathan Tang | M | - |
Tufts University
| 4 years |
Daniel Zilberman | M | 51 |
Tufts University
| 4 years |
Darren J. Brent | M | - |
Tufts University
| 4 years |
Jason Epstein | M | 51 |
Tufts University
| 4 years |
David Ben-Ur | M | - |
Tufts University
| 4 years |
Mitchell A. Davidson | M | - |
Tufts University
| 4 years |
Tom Foran | M | - |
Tufts University
| 4 years |
David M. Khtikian | M | - |
Tufts University
| 4 years |
Arthur Papas | M | - |
Tufts University
| 4 years |
John Schneider | M | - |
Tufts University
| 5 years |
John Murphy | M | - |
Tufts University
| 4 years |
Noah D. Yago | M | 48 |
Tufts University
| 4 years |
Ali Ismail Sabanci | M | 55 |
Tufts University
| 4 years |
Joshua Alpert | M | - |
Tufts University
| 4 years |
Jen Shigei | F | - |
Tufts University
| 4 years |
Kurt von Holzhausen | M | - |
Tufts University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 98 | 98.00% |
Brazil | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rosana Kapeller-Libermann
- Personal Network